Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations.
Khaeso K, Udayachalerm S, Komvilaisak P, Chainansamit SO, Suwannaying K, Laoaroon N, Kuwatjanakul P, Nakkam N, Sukasem C, Puangpetch A, Tassaneeyakul W, Chaiyakunapruk N.
Front Pharmacol. 2021 Dec 2;12:784712. doi: 10.3389/fphar.2021.784712. eCollection 2021.
PMID:34925040
Myelosuppression and its consequences in elderly patients with cancer.
Burden of chemotherapy-induced myelosuppression among patients with extensive-stage small cell lung cancer: A retrospective study from community oncology practices.
Hart L, Ogbonnaya A, Boykin K, Deyoung K, Bailey R, Heritage T, Lopez-Gonzalez L, Huang H, Gordan L.
Cancer Med. 2023 Apr;12(8):10020-10030. doi: 10.1002/cam4.5738. Epub 2023 Mar 31.
PMID:37000119
Comparison of myelosuppression using the D-index between children and adolescents/young adults with acute lymphoblastic leukemia during induction chemotherapy.
Matsushima S, Kobayashi R, Sano H, Hori D, Yanagi M, Kodama K, Suzuki D, Kobayashi K.